Search

The UK Phage Innovation Showcase will take place May 16th, 2023 from 9:30am-4pm in Leicester and online. The event is organized by Innovate UK KTN's Phage Innovation Network and the University of Leicester's recently launched Centre for Pha

The European Medicines Agency (EMA) is organizing a Focus Group meeting on 11 May 2023 to discuss the draft guideline on the quality, safety, and efficacy requirements for bacteriophage therapy in veterinary medicines. The aim is to establi

In this podcast, Dr. Jeremy Barr from Monash University and Phage Australia talks about his research on using phages to restore antimicrobial sensitivity in Acinetobacter baumannii.

University of Warwick and Cytiva authors show that poly(acrylic acid) prevents phage-induced killing of bacterial hosts and phage replication without affecting induction of recombinant protein expression, and was more active than poly(metha

Fixed Phage, a Glasgow based biotech company, has secured £1.5m investment to further scale development and commercialisation of its phage technology in the fight against antimicrobial resistance.

Federico Prokopczuk et al. engineered a superinfective phage (eSI-Pf) based on the Pf4 phage, which is able to infect Pseudomonas aeruginosa. They tested it as a phage therapy tool for the treatment of life-threatening burn wound infections

Talia Backman and colleagues published a new preprint on how a weaponized phage suppresses competitors in historical and modern metapopulations of pathogenic bacteria. The authors discovered a viral cluster shared amongst pathogenic Pseudom

Capsules and their traits affect phage susceptibility and plasmid conjugation efficiency, as per a preprint by Matthieu Haudiquet et al. They show that capsule swaps invert phage susceptibility and affect conjugation efficiency, with implic

Michael Schelling et al. published a new paper in PLOS Biology on how CRISPR-Cas effector specificity and cleavage site determine phage escape outcomes. They find that most pre-existing crRNA mismatches lead to phage escape, regardless of w

iPHoP, from the DOE Joint Genome Institute, is a two-step framework that integrates multiple methods to predict host taxonomy at the genus rank for viruses infecting bacteria and archaea while retaining a low false discovery rate. Applied t

From Timofey Skvortsov via Twitter: Hi all, where are you sequencing your new phage/bacterial isolates in the UK/Ireland these days? I'd appreciate any suggestions or insights!

In celebration of International Women's History Month, this episode of the Phage Files podcast looks back at female phage researchers' contributions to early phage research. The hosts interview Dr. Elizabeth Kutter (Evergreen State College)

In this episode of Breakpoints podcast, Dr. Saima Aslam and Dr. Daria Van Tyne join Dr. Rachel Britt for a discussion on phage therapy! Tune in for a review of their role in therapy, logistical considerations, the future of phage therapy, a

A European public consultation on a new general chapter in the European Pharmacopeia on phage therapy active substances and medicinal products of human and veterinary use is open (until end of June). This is a unique opportunity to help sha

IPATH's Translational Research in Bacteriophage Therapies Seminar Series has returned this year, featuring three speakers: Daria Van Tyne, Joseph Bondy-Denomy, and Austen Terwilliger. Watch recordings of them on YouTube, and catch upcoming

In this episode of Phage Therapy Today podcast, Dr. Gina Suh shares her recent progress and experience in applying phage therapy at Mayo Clinic.

Check out the Special Issue "The Phage: Biology and Therapeutic Use," published by Microorganisms and edited by Richard James (University of Nottingham) and David R. Harper (Evolution Biotechnologies). The deadline for manuscript submission

The Oxford Phage Meeting (Sept 4th-5th) is happening this year.

The Molecular Genetics of Bacteria and Phages Meeting in Madison, Wisconsin (Aug 7th-11th) is happening this year.

When the CDC reported a recent outbreak of extensively drug-resistant (XDR) Pseudomonas aeruginosa linked to artificial tears, IPATH's Co-Director, Chip Schooley, requested the Pseudomonas isolates associated with the outbreak. Fortunately,